[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mixed-phenotypic-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Mixed Phenotypic Leukemia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05110742","Phase I\u002FII Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed\u002FRefractory Hematological Malignances",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:40.612983Z","2026-07-30T01:46:14.462113Z",[],[]]